{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:48:18Z","timestamp":1786978098372,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304005"],"award-info":[{"award-number":["82304005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222059"],"award-info":[{"award-number":["82222059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330096"],"award-info":[{"award-number":["82330096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2023YFC2509005"],"award-info":[{"award-number":["2023YFC2509005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04512-1","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:24:08Z","timestamp":1767025448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dimethyl itaconate suppresses dendritic cell and CD8+ T cell responses to halt vitiligo"],"prefix":"10.1186","volume":"23","author":[{"given":"Yinghan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengran","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weinan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"4512_CR1","doi-asserted-by":"publisher","unstructured":"Ezzedine K, Tannous R, Pearson TF, Harris JE. Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity. J Clin Invest. 2025;135(2). https:\/\/doi.org\/10.1172\/JCI185785.","DOI":"10.1172\/JCI185785"},{"issue":"3","key":"4512_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","volume":"61","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li S, Li C. Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo. Clin Rev Allergy Immunol. 2021;61(3):299\u2013323. https:\/\/doi.org\/10.1007\/s12016-021-08868-z.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"4512_CR3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/med.21754","volume":"41","author":"J Chen","year":"2021","unstructured":"Chen J, Li S, Li C. Mechanisms of melanocyte death in vitiligo. Med Res Rev. 2021;41(2):1138\u201366. https:\/\/doi.org\/10.1002\/med.21754.","journal-title":"Med Res Rev"},{"issue":"7891","key":"4512_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","volume":"601","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen D, Hu Y, Jiang K, Huang H, Du Y, et al. Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Nature. 2022;601(7891):118\u201324. https:\/\/doi.org\/10.1038\/s41586-021-04221-8.","journal-title":"Nature"},{"issue":"9","key":"4512_CR5","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/jid.2009.32","volume":"129","author":"JG van den Boorn","year":"2009","unstructured":"van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol. 2009;129(9):2220\u201332. https:\/\/doi.org\/10.1038\/jid.2009.32.","journal-title":"J Invest Dermatol"},{"issue":"9988","key":"4512_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(14)60763-7.","journal-title":"Lancet"},{"issue":"10244","key":"4512_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0140-6736(20)30609-7","volume":"396","author":"D Rosmarin","year":"2020","unstructured":"Rosmarin D, Pandya AG, Lebwohl M, Grimes P, Hamzavi I, Gottlieb AB, et al. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. Lancet. 2020;396(10244):110\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(20)30609-7.","journal-title":"Lancet"},{"issue":"16","key":"4512_CR8","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","volume":"387","author":"D Rosmarin","year":"2022","unstructured":"Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, et al. Two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo. N Engl J Med. 2022;387(16):1445\u201355. https:\/\/doi.org\/10.1056\/NEJMoa2118828.","journal-title":"N Engl J Med"},{"key":"4512_CR9","doi-asserted-by":"publisher","unstructured":"Yang X, Ding W, Lou F, Xu H, Sheng A, Sun Y, et al. Nociceptor-derived CGRP enhances dermal type I conventional dendritic cell function to drive autoreactive CD8(+) T cell responses in vitiligo. Immunity. 2025;58(8):2086\u2013103e9. https:\/\/doi.org\/10.1016\/j.immuni.2025.05.018.","DOI":"10.1016\/j.immuni.2025.05.018"},{"issue":"9","key":"4512_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00403-020-02168-w","volume":"313","author":"N Srivastava","year":"2021","unstructured":"Srivastava N, Bishnoi A, Parsad D, Kumaran MS, Vinay K, Gupta S. Dendritic cells sub-sets are associated with inflammatory cytokine production in progressive vitiligo disease. Arch Dermatol Res. 2021;313(9):759\u201367. https:\/\/doi.org\/10.1007\/s00403-020-02168-w.","journal-title":"Arch Dermatol Res"},{"key":"4512_CR11","doi-asserted-by":"publisher","first-page":"155598","DOI":"10.1016\/j.cyto.2021.155598","volume":"148","author":"A Singh","year":"2021","unstructured":"Singh A, Das D, Kurra S, Arava S, Gupta S, Sharma A. Dendritic cells and their associated pro-inflammatory cytokines augment to the inflammatory milieu in vitiligo skin. Cytokine. 2021;148:155598. https:\/\/doi.org\/10.1016\/j.cyto.2021.155598.","journal-title":"Cytokine"},{"issue":"174","key":"4512_CR12","doi-asserted-by":"publisher","first-page":"174ra28","DOI":"10.1126\/scitranslmed.3005127","volume":"5","author":"JA Mosenson","year":"2013","unstructured":"Mosenson JA, Zloza A, Nieland JD, Garrett-Mayer E, Eby JM, Huelsmann EJ, et al. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013;5(174):174ra28. https:\/\/doi.org\/10.1126\/scitranslmed.3005127.","journal-title":"Sci Transl Med"},{"key":"4512_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2025.06.1596","author":"K Okamura","year":"2025","unstructured":"Okamura K, Arai Y, Kawaguchi J, Tsukada S, Nakamura A, Abe Y, et al. A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation. J Invest Dermatol. 2025. https:\/\/doi.org\/10.1016\/j.jid.2025.06.1596.","journal-title":"J Invest Dermatol"},{"key":"4512_CR14","doi-asserted-by":"publisher","unstructured":"Frisoli ML, Richmond JM, Harris JE. IL-12\/IL-23-Independent Function of BATF3-Dependent Dendritic Cells Is Required for Initiation of Disease in a Mouse Model of Vitiligo. J Invest Dermatol. 2024;144(11):2574\u20137e2. https:\/\/doi.org\/10.1016\/j.jid.2024.03.036.","DOI":"10.1016\/j.jid.2024.03.036"},{"issue":"5","key":"4512_CR15","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.molcel.2020.04.002","volume":"78","author":"Z Zaslona","year":"2020","unstructured":"Zaslona Z, O\u2019Neill LAJ. Cytokine-like Roles for Metabolites in Immunity. Mol Cell. 2020;78(5):814\u201323. https:\/\/doi.org\/10.1016\/j.molcel.2020.04.002.","journal-title":"Mol Cell"},{"key":"4512_CR16","doi-asserted-by":"publisher","unstructured":"Peace CG, O'Neill LA. The role of itaconate in host defense and inflammation. J Clin Invest. 2022;132(2). https:\/\/doi.org\/10.1172\/JCI148548.","DOI":"10.1172\/JCI148548"},{"key":"4512_CR17","doi-asserted-by":"publisher","unstructured":"Ogger PP, Albers GJ, Hewitt RJ, O'Sullivan BJ, Powell JE, Calamita E, et al. Itaconate controls the severity of pulmonary fibrosis. Sci Immunol. 2020;5(52). https:\/\/doi.org\/10.1126\/sciimmunol.abc1884.","DOI":"10.1126\/sciimmunol.abc1884"},{"key":"4512_CR18","doi-asserted-by":"publisher","unstructured":"Daly R, Blackburn G, Best C, Goodyear CS, Mudaliar M, Burgess K, et al. Changes in Plasma Itaconate Elevation in Early Rheumatoid Arthritis Patients Elucidates Disease Activity Associated Macrophage Activation. Metabolites. 2020;10(6). https:\/\/doi.org\/10.3390\/metabo10060241.","DOI":"10.3390\/metabo10060241"},{"issue":"7","key":"4512_CR19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s42255-020-0210-0","volume":"2","author":"A Swain","year":"2020","unstructured":"Swain A, Bambouskova M, Kim H, Andhey PS, Duncan D, Auclair K, et al. Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages. Nat Metab. 2020;2(7):594\u2013602. https:\/\/doi.org\/10.1038\/s42255-020-0210-0.","journal-title":"Nat Metab"},{"issue":"7699","key":"4512_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018;556(7699):113\u20137. https:\/\/doi.org\/10.1038\/nature25986.","journal-title":"Nature"},{"key":"4512_CR21","doi-asserted-by":"publisher","unstructured":"Hooftman A, Angiari S, Hester S, Corcoran SE, Runtsch MC, Ling C, et al. The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation. Cell Metab. 2020;32(3):468\u201378e7. https:\/\/doi.org\/10.1016\/j.cmet.2020.07.016.","DOI":"10.1016\/j.cmet.2020.07.016"},{"issue":"7702","key":"4512_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41586-018-0052-z","volume":"556","author":"M Bambouskova","year":"2018","unstructured":"Bambouskova M, Gorvel L, Lampropoulou V, Sergushichev A, Loginicheva E, Johnson K, et al. Electrophilic properties of itaconate and derivatives regulate the IkappaBzeta-ATF3 inflammatory axis. Nature. 2018;556(7702):501\u20134. https:\/\/doi.org\/10.1038\/s41586-018-0052-z.","journal-title":"Nature"},{"issue":"4","key":"4512_CR23","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.31147","volume":"72","author":"Z Yi","year":"2020","unstructured":"Yi Z, Deng M, Scott MJ, Fu G, Loughran PA, Lei Z, et al. Immune-responsive gene 1\/itaconate activates nuclear factor erythroid 2-related factor 2 in hepatocytes to protect against liver ischemia-reperfusion injury. Hepatology. 2020;72(4):1394\u2013411. https:\/\/doi.org\/10.1002\/hep.31147.","journal-title":"Hepatology"},{"key":"4512_CR24","doi-asserted-by":"publisher","unstructured":"Refat MA, Strassner JP, Frisoli ML, Rashighi M, Richmond J, Nada E, et al. Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo. J Invest Dermatol. 2023;143(11):2275\u201382e6. https:\/\/doi.org\/10.1016\/j.jid.2023.03.1689.","DOI":"10.1016\/j.jid.2023.03.1689"},{"issue":"9","key":"4512_CR25","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/jdv.15604","volume":"33","author":"N van Geel","year":"2019","unstructured":"van Geel N, Grine L, De Wispelaere P, Mertens D, Prinsen CAC, Speeckaert R. Clinical visible signs of disease activity in vitiligo: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019;33(9):1667\u201375. https:\/\/doi.org\/10.1111\/jdv.15604.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"4512_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jaci.2019.10.036","volume":"145","author":"S Li","year":"2020","unstructured":"Li S, Kang P, Zhang W, Jian Z, Zhang Q, Yi X, et al. Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo. J Allergy Clin Immunol. 2020;145(2):632\u201345. https:\/\/doi.org\/10.1016\/j.jaci.2019.10.036.","journal-title":"J Allergy Clin Immunol"},{"key":"4512_CR27","doi-asserted-by":"publisher","unstructured":"Molodtsov AK, Khatwani N, Vella JL, Lewis KA, Zhao Y, Han J, et al. Resident memory CD8(+) T cells in regional lymph nodes mediate immunity to metastatic melanoma. Immunity. 2021;54(9):2117\u201332e7. https:\/\/doi.org\/10.1016\/j.immuni.2021.08.019.","DOI":"10.1016\/j.immuni.2021.08.019"},{"issue":"5","key":"4512_CR28","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1172\/JCI44849","volume":"121","author":"KT Byrne","year":"2011","unstructured":"Byrne KT, Cote AL, Zhang P, Steinberg SM, Guo Y, Allie R, et al. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma. J Clin Invest. 2011;121(5):1797\u2013809. https:\/\/doi.org\/10.1172\/JCI44849.","journal-title":"J Clin Invest"},{"issue":"6","key":"4512_CR29","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1046\/j.0022-202x.2001.01605.x","volume":"117","author":"FA Le Gal","year":"2001","unstructured":"Le Gal FA, Avril MF, Bosq J, Lefebvre P, Deschemin JC, Andrieu M, et al. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo. J Invest Dermatol. 2001;117(6):1464\u201370. https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01605.x.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"4512_CR30","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1002\/cpim.63","volume":"124","author":"RL Riding","year":"2019","unstructured":"Riding RL, Richmond JM, Harris JE. Mouse model for human vitiligo. Curr Protoc Immunol. 2019;124(1):e63. https:\/\/doi.org\/10.1002\/cpim.63.","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"4512_CR31","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1038\/s41467-023-39174-1","volume":"14","author":"TAJ Ryan","year":"2023","unstructured":"Ryan TAJ, Hooftman A, Rehill AM, Johansen MD, Brien ECO, Toller-Kawahisa JE, et al. Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress tissue factor in macrophages via inhibition of type I interferon. Nat Commun. 2023;14(1):3513. https:\/\/doi.org\/10.1038\/s41467-023-39174-1.","journal-title":"Nat Commun"},{"key":"4512_CR32","unstructured":"Xu Z, Chen D, Hu Y, Jiang K, Huang H, Du Y, et al. Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Genome\u00a0Seq\u00a0Arch. https:\/\/ngdc.cncb.ac.cn\/bioproject\/browse\/PRJCA006797."},{"key":"4512_CR33","doi-asserted-by":"publisher","first-page":"1221260","DOI":"10.3389\/fimmu.2023.1221260","volume":"14","author":"P Yang","year":"2023","unstructured":"Yang P, Luan M, Li W, Niu M, He Q, Zhao Y, et al. Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo. Front Immunol. 2023;14:1221260. https:\/\/doi.org\/10.3389\/fimmu.2023.1221260.","journal-title":"Front Immunol"},{"key":"4512_CR34","unstructured":"Yang P, Luan M, Li W, Niu M, He Q, Zhao Y, et al. Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo. Gene Expression Omnibus https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE231794."},{"key":"4512_CR35","doi-asserted-by":"publisher","unstructured":"Li Y, Li S, Duan X, Yang C, Xu M, Chen L. Macrophage Phenotypes and Hepatitis B Virus Infection. J Clin Transl Hepatol. 2020;8(4):424\u201331. https:\/\/doi.org\/10.14218\/JCTH.2020.00046.","DOI":"10.14218\/JCTH.2020.00046"},{"issue":"4","key":"4512_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/ecco-jcc\/jjz170","volume":"14","author":"H Schmitt","year":"2020","unstructured":"Schmitt H, Ulmschneider J, Billmeier U, Vieth M, Scarozza P, Sonnewald S, et al. The TLR9 agonist cobitolimod induces IL10-producing wound healing macrophages and regulatory T cells in ulcerative colitis. J Crohns Colitis. 2020;14(4):508\u201324. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz170.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"4512_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-021-01490-9","volume":"21","author":"S Serrati","year":"2022","unstructured":"Serrati S, Guida M, Di Fonte R, De Summa S, Strippoli S, Iacobazzi RM, et al. Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma. Mol Cancer. 2022;21(1):20. https:\/\/doi.org\/10.1186\/s12943-021-01490-9.","journal-title":"Mol Cancer"},{"issue":"2","key":"4512_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-024-06483-2","volume":"15","author":"T Eberhart","year":"2024","unstructured":"Eberhart T, Stanley FU, Ricci L, Chirico T, Ferrarese R, Sisti S, et al. ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota. Cell Death Dis. 2024;15(2):105. https:\/\/doi.org\/10.1038\/s41419-024-06483-2.","journal-title":"Cell Death Dis"},{"issue":"12","key":"4512_CR39","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1074\/jbc.C117.775270","volume":"292","author":"M ElAzzouny","year":"2017","unstructured":"ElAzzouny M, Tom CT, Evans CR, Olson LL, Tanga MJ, Gallagher KA, et al. Dimethyl itaconate is not metabolized into itaconate intracellularly. J Biol Chem. 2017;292(12):4766\u20139. https:\/\/doi.org\/10.1074\/jbc.C117.775270.","journal-title":"J Biol Chem"},{"issue":"2","key":"4512_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41590-020-00829-6","volume":"22","author":"M Gu","year":"2021","unstructured":"Gu M, Zhou X, Sohn JH, Zhu L, Jie Z, Yang JY, et al. NF-kappaB-inducing kinase maintains T cell metabolic fitness in antitumor immunity. Nat Immunol. 2021;22(2):193\u2013204. https:\/\/doi.org\/10.1038\/s41590-020-00829-6.","journal-title":"Nat Immunol"},{"issue":"5","key":"4512_CR41","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.4049\/jimmunol.1700812","volume":"200","author":"S Noel","year":"2018","unstructured":"Noel S, Lee SA, Sadasivam M, Hamad ARA, Rabb H. KEAP1 editing using CRISPR\/Cas9 for therapeutic NRF2 activation in primary human T lymphocytes. J Immunol. 2018;200(5):1929\u201336. https:\/\/doi.org\/10.4049\/jimmunol.1700812.","journal-title":"J Immunol"},{"issue":"8","key":"4512_CR42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","volume":"41","author":"W Luo","year":"2020","unstructured":"Luo W, Li YX, Jiang LJ, Chen Q, Wang T, Ye DW. Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19. Trends Pharmacol Sci. 2020;41(8):531\u201343. https:\/\/doi.org\/10.1016\/j.tips.2020.06.007.","journal-title":"Trends Pharmacol Sci"},{"issue":"21","key":"4512_CR43","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL, Wang Y, Cheon H, Kanno Y, Gadina M, Sartorelli V, et al. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185(21):3857\u201376. https:\/\/doi.org\/10.1016\/j.cell.2022.09.023.","journal-title":"Cell"},{"key":"4512_CR44","doi-asserted-by":"publisher","unstructured":"Gleave A, Granville DJ. Granzyme B in Autoimmune Skin Disease. Biomolecules. 2023;13(2). https:\/\/doi.org\/10.3390\/biom13020388.","DOI":"10.3390\/biom13020388"},{"issue":"2","key":"4512_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","volume":"46","author":"S Cheuk","year":"2017","unstructured":"Cheuk S, Schlums H, Gallais Serezal I, Martini E, Chiang SC, Marquardt N, et al. CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin. Immunity. 2017;46(2):287\u2013300. https:\/\/doi.org\/10.1016\/j.immuni.2017.01.009.","journal-title":"Immunity"},{"key":"4512_CR46","doi-asserted-by":"publisher","unstructured":"Boukhedouni N, Martins C, Darrigade AS, Drullion C, Rambert J, Barrault C, et al. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo. JCI Insight. 2020;5(11). https:\/\/doi.org\/10.1172\/jci.insight.133772.","DOI":"10.1172\/jci.insight.133772"},{"issue":"6","key":"4512_CR47","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.immuni.2015.11.005","volume":"43","author":"AS Rapaport","year":"2015","unstructured":"Rapaport AS, Schriewer J, Gilfillan S, Hembrador E, Crump R, Plougastel BF, et al. The inhibitory receptor NKG2A sustains virus-specific CD8(+) T cells in response to a lethal poxvirus infection. Immunity. 2015;43(6):1112\u201324. https:\/\/doi.org\/10.1016\/j.immuni.2015.11.005.","journal-title":"Immunity"},{"key":"4512_CR48","doi-asserted-by":"publisher","first-page":"1006996","DOI":"10.3389\/fimmu.2022.1006996","volume":"13","author":"FB Sulczewski","year":"2022","unstructured":"Sulczewski FB, Martino LA, Salles D, Yamamoto MM, Rosa DS, Boscardin SB. STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptor. Front Immunol. 2022;13:1006996. https:\/\/doi.org\/10.3389\/fimmu.2022.1006996.","journal-title":"Front Immunol"},{"issue":"1","key":"4512_CR49","doi-asserted-by":"publisher","first-page":"111991","DOI":"10.1016\/j.celrep.2023.111991","volume":"42","author":"J Liu","year":"2023","unstructured":"Liu J, Cheng Y, Zhang X, Chen Y, Zhu H, Chen K, et al. Glycosyltransferase Extl1 promotes CCR7-mediated dendritic cell migration to restrain infection and autoimmunity. Cell Rep. 2023;42(1):111991. https:\/\/doi.org\/10.1016\/j.celrep.2023.111991.","journal-title":"Cell Rep"},{"issue":"4","key":"4512_CR50","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","volume":"50","author":"ED Tait Wojno","year":"2019","unstructured":"Tait Wojno ED, Hunter CA, Stumhofer JS. The immunobiology of the interleukin-12 family: room for discovery. Immunity. 2019;50(4):851\u201370. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.011.","journal-title":"Immunity"},{"key":"4512_CR51","doi-asserted-by":"publisher","unstructured":"Shiu J, Zhang L, Lentsch G, Flesher JL, Jin S, Polleys C, et al. Multimodal analyses of vitiligo skin identify tissue characteristics of stable disease. JCI Insight. 2022;7(13). https:\/\/doi.org\/10.1172\/jci.insight.154585.","DOI":"10.1172\/jci.insight.154585"},{"issue":"2","key":"4512_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703.","journal-title":"J Basic Clin Pharm"},{"key":"4512_CR53","volume-title":"Bioassays in Experimental and Preclinical Pharmacology","author":"SPS KaruppusamyArunachalam","year":"2021","unstructured":"KaruppusamyArunachalam SPS. Bioassays in Experimental and Preclinical Pharmacology. 1st ed. NY: Springer; Humana New York; 2021.","edition":"1"},{"issue":"8","key":"4512_CR54","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41418-024-01303-8","volume":"31","author":"C Wei","year":"2024","unstructured":"Wei C, Xiao Z, Zhang Y, Luo Z, Liu D, Hu L, et al. Itaconate protects ferroptotic neurons by alkylating GPx4 post stroke. Cell Death Differ. 2024;31(8):983\u201398. https:\/\/doi.org\/10.1038\/s41418-024-01303-8.","journal-title":"Cell Death Differ"},{"issue":"7\u20138","key":"4512_CR55","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.nut.2013.11.023","volume":"30","author":"S Pereira","year":"2014","unstructured":"Pereira S, Teixeira L, Aguilar E, Oliveira M, Savassi-Rocha A, Pelaez JN, et al. Modulation of adipose tissue inflammation by FOXP3+ Treg cells, IL-10, and TGF-\u03b2 in metabolically healthy class III obese individuals. Nutrition. 2014;30(7\u20138):784\u201390. https:\/\/doi.org\/10.1016\/j.nut.2013.11.023.","journal-title":"Nutrition"},{"issue":"3","key":"4512_CR56","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.immuni.2012.06.017","volume":"37","author":"M Khounlotham","year":"2012","unstructured":"Khounlotham M, Kim W, Peatman E, Nava P, Medina-Contreras O, Addis C, et al. Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity. 2012;37(3):563\u201373. https:\/\/doi.org\/10.1016\/j.immuni.2012.06.017.","journal-title":"Immunity"},{"issue":"6","key":"4512_CR57","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140(6):871\u201382. https:\/\/doi.org\/10.1016\/j.cell.2010.02.029.","journal-title":"Cell"},{"issue":"4","key":"4512_CR58","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.immuni.2022.03.016","volume":"55","author":"C Nathan","year":"2022","unstructured":"Nathan C. Nonresolving inflammation redux. Immunity. 2022;55(4):592\u2013605. https:\/\/doi.org\/10.1016\/j.immuni.2022.03.016.","journal-title":"Immunity"},{"issue":"5","key":"4512_CR59","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41577-019-0128-5","volume":"19","author":"LAJ O'Neill","year":"2019","unstructured":"O\u2019Neill LAJ, Artyomov MN. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat Rev Immunol. 2019;19(5):273\u201381. https:\/\/doi.org\/10.1038\/s41577-019-0128-5.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"4512_CR60","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s42255-022-00676-9","volume":"4","author":"H Zhao","year":"2022","unstructured":"Zhao H, Teng D, Yang L, Xu X, Chen J, Jiang T, et al. Myeloid-derived itaconate suppresses cytotoxic CD8(+) T cells and promotes tumour growth. Nat Metab. 2022;4(12):1660\u201373. https:\/\/doi.org\/10.1038\/s42255-022-00676-9.","journal-title":"Nat Metab"},{"key":"4512_CR61","doi-asserted-by":"publisher","first-page":"669308","DOI":"10.3389\/fchem.2021.669308","volume":"9","author":"J Lin","year":"2021","unstructured":"Lin J, Ren J, Gao DS, Dai Y, Yu L. The emerging application of itaconate: promising molecular targets and therapeutic opportunities. Front Chem. 2021;9:669308. https:\/\/doi.org\/10.3389\/fchem.2021.669308.","journal-title":"Front Chem"},{"issue":"2","key":"4512_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10753-020-01352-4","volume":"44","author":"S Zhang","year":"2021","unstructured":"Zhang S, Jiao Y, Li C, Liang X, Jia H, Nie Z, et al. Dimethyl itaconate alleviates the inflammatory responses of macrophages in sepsis. Inflammation. 2021;44(2):549\u201357. https:\/\/doi.org\/10.1007\/s10753-020-01352-4.","journal-title":"Inflammation"},{"issue":"659","key":"4512_CR63","doi-asserted-by":"publisher","first-page":"eabo2028","DOI":"10.1126\/scitranslmed.abo2028","volume":"14","author":"R Wu","year":"2022","unstructured":"Wu R, Liu J, Wang N, Zeng L, Yu C, Chen F, et al. Aconitate decarboxylase 1 is a mediator of polymicrobial sepsis. Sci Transl Med. 2022;14(659):eabo2028. https:\/\/doi.org\/10.1126\/scitranslmed.abo2028.","journal-title":"Sci Transl Med"},{"key":"4512_CR64","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev-cellbio-111315-125324","volume":"32","author":"NR Gascoigne","year":"2016","unstructured":"Gascoigne NR, Rybakin V, Acuto O, Brzostek J. TCR signal strength and T cell development. Annu Rev Cell Dev Biol. 2016;32:327\u201348. https:\/\/doi.org\/10.1146\/annurev-cellbio-111315-125324.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4512_CR65","doi-asserted-by":"publisher","unstructured":"Nguyen QP, Takehara KK, Deng TZ, O'Shea S, Heeg M, Omilusik KD, et al. Transcriptional programming of CD4(+) T(RM) differentiation in viral infection balances effector- and memory-associated gene expression. Sci Immunol. 2023;8(83):eabq7486. https:\/\/doi.org\/10.1126\/sciimmunol.abq7486.","DOI":"10.1126\/sciimmunol.abq7486"},{"issue":"5","key":"4512_CR66","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.smim.2016.10.009","volume":"28","author":"L Almeida","year":"2016","unstructured":"Almeida L, Lochner M, Berod L, Sparwasser T. Metabolic pathways in T cell activation and lineage differentiation. Semin Immunol. 2016;28(5):514\u201324. https:\/\/doi.org\/10.1016\/j.smim.2016.10.009.","journal-title":"Semin Immunol"},{"issue":"1","key":"4512_CR67","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000530249","volume":"15","author":"M Simon-Fuentes","year":"2023","unstructured":"Simon-Fuentes M, Herrero C, Acero-Riaguas L, Nieto C, Lasala F, Labiod N, et al. TLR7 activation in M-CSF-dependent monocyte-derived human macrophages potentiates inflammatory responses and prompts neutrophil recruitment. J Innate Immun. 2023;15(1):517\u201330. https:\/\/doi.org\/10.1159\/000530249.","journal-title":"J Innate Immun"},{"issue":"3","key":"4512_CR68","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41556-022-00853-8","volume":"24","author":"LL Chen","year":"2022","unstructured":"Chen LL, Morcelle C, Cheng ZL, Chen X, Xu Y, Gao Y, et al. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses. Nat Cell Biol. 2022;24(3):353\u201363. https:\/\/doi.org\/10.1038\/s41556-022-00853-8.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4512_CR69","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1038\/s41467-019-13078-5","volume":"10","author":"ST Liao","year":"2019","unstructured":"Liao ST, Han C, Xu DQ, Fu XW, Wang JS, Kong LY. 4-octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. Nat Commun. 2019;10(1):5091. https:\/\/doi.org\/10.1038\/s41467-019-13078-5.","journal-title":"Nat Commun"},{"key":"4512_CR70","doi-asserted-by":"publisher","unstructured":"Azzolino V, Zapata L, Jr., Garg M, Gjoni M, Riding RL, Strassner JP, et al. Jak Inhibitors Reverse Vitiligo in Mice but Do Not Deplete Skin Resident Memory T Cells. J Invest Dermatol. 2021;141(1):182\u20134 e1. https:\/\/doi.org\/10.1016\/j.jid.2020.04.027.","DOI":"10.1016\/j.jid.2020.04.027"},{"issue":"1","key":"4512_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/HEP.0000000000000549","volume":"79","author":"Y Li","year":"2024","unstructured":"Li Y, Li B, Xiao X, Qian Q, Wang R, Lyu Z, et al. Itaconate inhibits CD103 + T RM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis. Hepatology. 2024;79(1):25\u201338. https:\/\/doi.org\/10.1097\/HEP.0000000000000549.","journal-title":"Hepatology"},{"issue":"11","key":"4512_CR72","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","volume":"18","author":"J Liu","year":"2021","unstructured":"Liu J, Zhang X, Cheng Y, Cao X. Dendritic cell migration in inflammation and immunity. Cell Mol Immunol. 2021;18(11):2461\u201371. https:\/\/doi.org\/10.1038\/s41423-021-00726-4.","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"4512_CR73","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.4049\/jimmunol.162.9.5287","volume":"162","author":"H Matsue","year":"1999","unstructured":"Matsue H, Edelbaum D, Hartmann AC, Morita A, Bergstresser PR, Yagita H, et al. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells. J Immunol. 1999;162(9):5287\u201398.","journal-title":"J Immunol"},{"issue":"12","key":"4512_CR74","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1084\/jem.185.12.2133","volume":"185","author":"E Ingulli","year":"1997","unstructured":"Ingulli E, Mondino A, Khoruts A, Jenkins MK. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J Exp Med. 1997;185(12):2133\u201341. https:\/\/doi.org\/10.1084\/jem.185.12.2133.","journal-title":"J Exp Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04512-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04512-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04512-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:24:10Z","timestamp":1767025450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-025-04512-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4512"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04512-1","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human studies were approved by the Ethics Committee of the First Affiliated Hospital of Fourth Military Medical University (KY20172030-1) in accordance with the Declaration of Helsinki Principles. All animal experimental procedures were performed in accordance with the guidelines of the Guide for the Care and Use of Laboratory Animals of the Fourth Military Medical University and were complied with relevant ethical rules.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents for publication were provided by all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"698"}}